Coronary vascular dysfunction in premenopausal women with diabetes mellitus

Marcelo F Di Carli1, Luis Afonso, Roxana Campisi

  • 1Department of Medicine, Wayne State University School of Medicine, Detroit, Mich, USA. mdicarli@partners.org

American Heart Journal
|October 3, 2002
PubMed

Insights

Premenopausal women with diabetes exhibit impaired coronary vascular function, similar to postmenopausal women. This suggests diabetes exacerbates cardiovascular risk by affecting blood flow regulation in coronary arteries.

Area of Science:

  • Cardiovascular physiology
  • Endocrinology
  • Women's health

Background:

  • Diabetes mellitus eliminates the sex difference in coronary artery disease (CAD) risk in premenopausal women.
  • This suggests diabetes-associated cardiovascular risk may stem from mechanisms beyond typical risk factors, potentially involving impaired coronary vascular function.
  • Investigating diabetes' impact on coronary vascular function in premenopausal women is crucial for understanding this elevated risk.

Purpose of the Study:

  • To investigate the effect of diabetes mellitus on coronary vascular function in premenopausal women.
  • To compare coronary vascular function in premenopausal women with and without diabetes, as well as with postmenopausal women.

Main Methods:

  • Positron emission tomography (PET) with [13N]-ammonia was used to measure myocardial blood flow (MBF).
  • MBF was assessed at rest, during hyperemia, and in response to cold pressor testing (CPT) in 13 premenopausal women with diabetes, 12 age-matched premenopausal controls, and 9 postmenopausal controls.
  • Coronary vascular resistance (CVR) was calculated, and responses were adjusted for rate-pressure product and metabolic abnormalities.

Main Results:

  • While all groups showed increased MBF during hyperemia, the percentage increase was significantly lower in women with diabetes compared to premenopausal controls (164% vs. 258%, P=.021).
  • The response to CPT was also significantly blunted in women with diabetes compared to premenopausal controls (24% vs. 60%, P=.013).
  • These impaired vasodilator and sympathetic responses in diabetic women were similar to those in postmenopausal controls and persisted after adjustments.

Conclusions:

  • Premenopausal women with diabetes demonstrate reduced coronary vasodilator function.
  • These women also exhibit an impaired response of coronary resistance vessels to sympathetic stimulation, mirroring findings in postmenopausal women.
  • These vascular dysfunctions likely contribute to the increased cardiovascular risk observed in premenopausal women with diabetes.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.